Patient perception of medical care for psoriatic arthritis in North America and Europe: results from a global patient survey
<p><strong>Objective:</strong> To compare perceptions of disease control and treatment satisfaction between patients with psoriatic arthritis (PsA) in North America and Europe, and between participating countries within each region.</p> <p><strong>Methods:</st...
| Váldodahkkit: | , , , , , , , |
|---|---|
| Materiálatiipa: | Journal article |
| Giella: | English |
| Almmustuhtton: |
Springer
2022
|
| _version_ | 1826308192946094080 |
|---|---|
| author | Richette, P Coates, LC Azevedo, VF Cappelleri, JC Moser, J Queiro-Silva, R Fallon, L Kessouri, M |
| author_facet | Richette, P Coates, LC Azevedo, VF Cappelleri, JC Moser, J Queiro-Silva, R Fallon, L Kessouri, M |
| author_sort | Richette, P |
| collection | OXFORD |
| description | <p><strong>Objective:</strong> To compare perceptions of disease control and treatment satisfaction between patients with psoriatic arthritis (PsA) in North America and Europe, and between participating countries within each region.</p>
<p><strong>Methods:</strong> Data were collected from patients with self-reported PsA diagnoses using an online survey. Results from questions on perceptions of overall health, disease severity, PsA symptoms, PsA impacts, and treatment satisfaction/preferences were reported using descriptive statistics and chi-square tests.</p>
<p><strong>Results:</strong> 456 patients from North America (Canada, n=155; US, n=301) and 417 patients from Europe (France, n=123; Spain, n=135; UK, n=159) were included in this analysis. Patients in North America were more likely to rate their overall health as excellent/good compared with those in Europe (49% vs. 14%), but also rate their disease as severe (27% vs. 15%). Despite treatment, patients in North America and Europe still experienced musculoskeletal (92% vs. 91%) and skin/nail (62% vs. 58%) symptoms. Similar proportions of patients in North America vs. Europe experienced a social impact (81% vs. 85%); more patients in Europe vs. North America experienced PsA-related work impacts (83% vs. 74%). Satisfaction with PsA medication was more common in North America (89%) vs. Europe (79%), and more common in Spain (91%) vs. the UK (82%) or France (66%). Across all regions and countries, ≥75% of patients agreed symptoms were controlled. However, ≥66% wished they had more medication choices, and ≥84% wanted to change something about their medication.</p>
<p><strong>Conclusion:</strong> Although perception of overall health and disease severity varied, many patients from both regions still experienced symptoms despite receiving medications for PsA, wished they had greater choice of medications and/or would like to change an aspect of their medications. While these survey findings are subject to selection bias, they do indicate there is scope to improve the treatment of PsA.</p> |
| first_indexed | 2024-03-07T07:15:51Z |
| format | Journal article |
| id | oxford-uuid:c9aaa1f7-a282-4331-a458-90999a056e01 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:15:51Z |
| publishDate | 2022 |
| publisher | Springer |
| record_format | dspace |
| spelling | oxford-uuid:c9aaa1f7-a282-4331-a458-90999a056e012022-08-05T08:31:46ZPatient perception of medical care for psoriatic arthritis in North America and Europe: results from a global patient surveyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c9aaa1f7-a282-4331-a458-90999a056e01EnglishSymplectic ElementsSpringer2022Richette, PCoates, LCAzevedo, VFCappelleri, JCMoser, JQueiro-Silva, RFallon, LKessouri, M<p><strong>Objective:</strong> To compare perceptions of disease control and treatment satisfaction between patients with psoriatic arthritis (PsA) in North America and Europe, and between participating countries within each region.</p> <p><strong>Methods:</strong> Data were collected from patients with self-reported PsA diagnoses using an online survey. Results from questions on perceptions of overall health, disease severity, PsA symptoms, PsA impacts, and treatment satisfaction/preferences were reported using descriptive statistics and chi-square tests.</p> <p><strong>Results:</strong> 456 patients from North America (Canada, n=155; US, n=301) and 417 patients from Europe (France, n=123; Spain, n=135; UK, n=159) were included in this analysis. Patients in North America were more likely to rate their overall health as excellent/good compared with those in Europe (49% vs. 14%), but also rate their disease as severe (27% vs. 15%). Despite treatment, patients in North America and Europe still experienced musculoskeletal (92% vs. 91%) and skin/nail (62% vs. 58%) symptoms. Similar proportions of patients in North America vs. Europe experienced a social impact (81% vs. 85%); more patients in Europe vs. North America experienced PsA-related work impacts (83% vs. 74%). Satisfaction with PsA medication was more common in North America (89%) vs. Europe (79%), and more common in Spain (91%) vs. the UK (82%) or France (66%). Across all regions and countries, ≥75% of patients agreed symptoms were controlled. However, ≥66% wished they had more medication choices, and ≥84% wanted to change something about their medication.</p> <p><strong>Conclusion:</strong> Although perception of overall health and disease severity varied, many patients from both regions still experienced symptoms despite receiving medications for PsA, wished they had greater choice of medications and/or would like to change an aspect of their medications. While these survey findings are subject to selection bias, they do indicate there is scope to improve the treatment of PsA.</p> |
| spellingShingle | Richette, P Coates, LC Azevedo, VF Cappelleri, JC Moser, J Queiro-Silva, R Fallon, L Kessouri, M Patient perception of medical care for psoriatic arthritis in North America and Europe: results from a global patient survey |
| title | Patient perception of medical care for psoriatic arthritis in North America and Europe: results from a global patient survey |
| title_full | Patient perception of medical care for psoriatic arthritis in North America and Europe: results from a global patient survey |
| title_fullStr | Patient perception of medical care for psoriatic arthritis in North America and Europe: results from a global patient survey |
| title_full_unstemmed | Patient perception of medical care for psoriatic arthritis in North America and Europe: results from a global patient survey |
| title_short | Patient perception of medical care for psoriatic arthritis in North America and Europe: results from a global patient survey |
| title_sort | patient perception of medical care for psoriatic arthritis in north america and europe results from a global patient survey |
| work_keys_str_mv | AT richettep patientperceptionofmedicalcareforpsoriaticarthritisinnorthamericaandeuroperesultsfromaglobalpatientsurvey AT coateslc patientperceptionofmedicalcareforpsoriaticarthritisinnorthamericaandeuroperesultsfromaglobalpatientsurvey AT azevedovf patientperceptionofmedicalcareforpsoriaticarthritisinnorthamericaandeuroperesultsfromaglobalpatientsurvey AT cappellerijc patientperceptionofmedicalcareforpsoriaticarthritisinnorthamericaandeuroperesultsfromaglobalpatientsurvey AT moserj patientperceptionofmedicalcareforpsoriaticarthritisinnorthamericaandeuroperesultsfromaglobalpatientsurvey AT queirosilvar patientperceptionofmedicalcareforpsoriaticarthritisinnorthamericaandeuroperesultsfromaglobalpatientsurvey AT fallonl patientperceptionofmedicalcareforpsoriaticarthritisinnorthamericaandeuroperesultsfromaglobalpatientsurvey AT kessourim patientperceptionofmedicalcareforpsoriaticarthritisinnorthamericaandeuroperesultsfromaglobalpatientsurvey |